![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
http://orcid.org/0000-0001-8049-1476
References
- Kim SH, Yang DM, Kim SH. 2005. Borderline serous surface papillary tumor of the ovary: MRI characteristics. American Journal of Roentgenology 184:1898–1900.
- Kitajima K, Suzuki K, Senda M, Kita M, Nakamoto Y, Onishi Y, et al. 2011. FDG-PET/CT for diagnosis of primary ovarian cancer. Nuclear medicine communications 32: 549–553.
- Kwon Y, Park SB, Lee JB, Park HJ. 2013. Sonographic findings of an ovarian serous surface papillary borderline tumor. Clinical Imaging 37:1128–1130.
- Naqvi J, Nagaraju E, Ahmad S. 2015. MRI appearances of pure epithelial papillary serous borderline ovarian tumours. Clinical Radiology 70:424–432.
- Park SB, Kim MJ, Lee KH, Ko Y. 2018. Ovarian serous surface papillary borderline tumor: characteristic imaging features with clinicopathological correlation. The British Journal of Radiology 91:20170689.
- Prakash P, Cronin CG, Blake MA. 2010. Role of PET/CT in ovarian cancer. American Journal of Roentgenology 194:W464–W470.
- Risum S, Høgdall C, Loft A, Berthelsen AK, Høgdall E, Nedergaard L, et al. 2007. The diagnostic value of PET/CT for primary ovarian cancer—a prospective study. Gynecologic Oncology 105:145–149.
- Tanaka YO, Okada S, Satoh T, Matsumoto K, Oki A, Nishida M, et al. 2011. Ovarian serous surface papillary borderline tumors form sea anemone‐like masses. Journal of Magnetic Resonance Imaging 33:633–640.
- Tanizaki Y, Kobayashi A, Shiro M, Ota N, Takano R, Mabuchi Y, et al. 2014. Diagnostic value of preoperative SUVmax on FDG-PET/CT for the detection of ovarian cancer. International Journal of Gynecological Cancer 24:454–460.